Skip to content

Randomized Comparison of Radiological Exposure With TRIPTable® in Patients With Acute Coronary Syndromes

Randomized Comparison of Radiological Exposure Between Radial and Femoral Technique Assessing Use of Protective Device Dedicated TRIPTable® in Patients With Acute Coronary Syndromes Undergoing Cardiac Catheterization

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02200783
Acronym
TRIPTABLE
Enrollment
99
Registered
2014-07-25
Start date
2014-07-31
Completion date
2015-12-31
Last updated
2015-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes, Angioplasty, Transluminal, Percutaneous Coronary

Keywords

Cardiac catheterization, Radiation Protection, Radial artery, Femoral artery

Brief summary

Excessive radiation received by the operator has been described as a possible drawback of the radial catheterization technique when compared with the femoral access. The study hypothesis is that the use of radial access device dedicated radioprotective TRIPTable ® (Transradial Intervention Table Protection) is not inferior to standard femoral technique and superior to standard radial technique as radioprotection strategy to the operator in patients with acute coronary syndromes acute and submitted to cardiac catheterization.

Detailed description

This study is prospective, 1:1:1 randomized, unicentric, comparative between femoral and radial radial technique with and without dedicated TRIPTable ® device. The TripTable device is a polycarbonate support table anatomically-designed to facilitate the radial technique, facilitating the puncturing, positioning, support to work material and providing further radioprotection from a lead layer without obstruction in viewing the fluoroscopic images.

Interventions

DEVICERadial

Standard radial artery catheterization procedure, performed for the purpose of coronary angiography and ad hoc angioplasty if necessary.

DEVICETripTable

Details of the device previously described, designed to medical operator radioprotection. No changes in radial technique beyond the use of the supportive device will be performed.

DEVICEFemoral

Standard femoral artery catheterization procedure, performed for the purpose of coronary angiography and ad hoc angioplasty if necessary. The supporting device will be the patient's own body, placing the material above the legs.

Sponsors

Marilia Medicine School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Unstable angina with an indication for invasive stratification * Acute coronary syndrome without ST-segment elevation * Acute coronary syndrome with ST-segment elevation * Patient informed of the nature of the study and have signed the Informed Consent * Patient suitable for coronary angiography and / or percutaneous coronary intervention either by radial access as the femoral

Exclusion criteria

* Below 18 years of age * Pregnancy * Chronic use of vitamin K antagonists, or direct thrombin inhibitors or antagonists of factor Xa, * Active bleeding or high risk of bleeding (severe hepatic insufficiency, active peptic ulcer disease, creatinine clearance \<30 mL / min, platelet count \<100,000 mm3); * Uncontrolled hypertension; * Cardiogenic shock; * Previous coronary artery bypass graft surgery with the use of ≥ 1 graft * Patients not candidates for the use of any of the specified vascular access * Concomitant severe disease with life expectancy less than 12 months life; * Medical, geographical, or social conditions that impede study participation * Refusal or inability to understand and sign the informed consent form.

Design outcomes

Primary

MeasureTime frameDescription
Radiation dose1 yearAccumulated radiation dose received by the operator during the interventional cardiology procedures as measured by Thermoluminescent Dosimeters (TLD)

Secondary

MeasureTime frameDescription
Radiation according measured site1 yearaccumulated radiation dose received by each measured site (gonadal, thyroid and lens)
Operator absorbed radiation according total radiation dose1 yearEvaluation of radiation dose to the operator according to linear correlation corrected for total dose of radiation.
Success of procedure1 yearSuccess rate of the procedure, as defined by perform the procedure without need to cross between techniques

Other

MeasureTime frameDescription
Clinical data1 yearRegistration of clinical features and procedural data, to compare with historical control group (ARISE trial - NCT01653587) using similar inclusion criteria without the objectives of the current study operator (to exclude Hawthorne effect).

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026